Verition Fund Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$225K Buy
2024
Q3
$191K Sell
2024
Q2
$218K Buy
2023
Q4
Sell
2023
Q3
$68.9K Buy
2021
Q3
Sell
2021
Q2
$309K Buy